Ciro Chiappini,Yaping Chen,Stella Aslanoglou,Anna Mariano,Valentina Mollo,Huanwen Mu,Enrica De Rosa,Gen He,Ennio Tasciotti,Xi Xie,Francesca Santoro,Wenting Zhao,Nicolas H. Voelcker,Roey Elnathan
Abstract:Intracellular delivery of advanced therapeutics, including biologicals and supramolecular agents, is complex because of the natural biological barriers that have evolved to protect the cell. Efficient delivery of therapeutic nucleic acids, proteins, peptides and nanoparticles is crucial for clinical adoption of emerging technologies that can benefit disease treatment through gene and cell therapy. Nanoneedles are arrays of vertical high-aspect-ratio nanostructures that can precisely manipulate complex processes at the cell interface, enabling effective intracellular delivery. This emerging technology has already enabled the development of efficient and non-destructive routes for direct access to intracellular environments and delivery of cell-impermeant payloads. However, successful implementation of this technology requires knowledge of several scientific fields, making it complex to access and adopt by researchers who are not directly involved in developing nanoneedle platforms. This presents an obstacle to the widespread adoption of nanoneedle technologies for drug delivery. This tutorial aims to equip researchers with the knowledge required to develop a nanoinjection workflow. It discusses the selection of nanoneedle devices, approaches for cargo loading and strategies for interfacing to biological systems and summarises an array of bioassays that can be used to evaluate the efficacy of intracellular delivery.
What problem does this paper attempt to address?
The paper primarily discusses the application of nanoneedles in the intracellular delivery of drugs and biomolecules, aiming to address the challenge of efficiently and harmlessly delivering various therapeutic substances directly into cells. Traditionally, a variety of delivery methods, including viral, chemical, and physical approaches, have been able to achieve a certain level of efficiency, but their effectiveness is often limited by specific types of payloads and cell/tissue types, hindering the widespread application of gene and cell therapies.
The nanoinjection technology mentioned in the paper is a physical delivery method that utilizes nanostructures with high aspect ratios—nanoneedles—to penetrate biological barriers effectively with minimal cellular disturbance and invasiveness, making it highly suitable as a universal platform for intracellular delivery. Nanoneedle technology is highly biocompatible and safe, applicable to a wide range of payload types, and harmless to cells, including sensitive cells such as primary neurons, cardiomyocytes, and immune cells. Moreover, nanoneedles can also deliver multiple payloads in a coordinated manner and achieve precise temporal and spatial control.
However, establishing an effective interface between nanoneedles and living mammalian cells/tissues for efficient intracellular delivery remains a challenge. To address this issue, the paper discusses four key factors that determine the outcome of nanoinjection: the choice of nanoneedle device, the type of payload and its loading/release mechanism, the target biological system, and the interface method. Additionally, various biological assays used to evaluate the effectiveness and performance of nanoinjection are discussed.
Nanoneedle devices can be categorized as solid, porous, or hollow, each with its characteristics and suitable scenarios. For example, solid nanowires are simple to manufacture and suitable for spontaneous cell interfaces, while porous and hollow nanoneedles offer more complex payload control and release functions. Electroactivity integrated into the nanoneedles further enhances their functionality, such as improving delivery efficiency and control through localized electroporation. Different manufacturing methods, such as chemical vapor deposition (CVD), reactive ion etching (RIE), and metal-assisted chemical etching (MACE), are used to prepare various types of nanoneedles, each with its advantages and limitations.
In summary, the goal of this paper is to provide researchers with the necessary knowledge to develop nanoinjection workflows, enabling them to select appropriate nanoneedle devices, payload loading strategies, and biological system interface modes to achieve efficient and controllable intracellular delivery.